Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Mar 25, 2021 1:21pm
175 Views
Post# 32876256

RE:RE:RE:RE:RE:RE:RE:RE:RE:Sigilon

RE:RE:RE:RE:RE:RE:RE:RE:RE:SigilonLots of assumptions here Reddy but I fully expect this from you.

My main points you've purposely missed to spread your rose tint rhetoric. I am fully aware what an NDA is but my point is that they should have negotiated the use of the pharma NAME upon signing. I'm not suggesting that they should fill investors in on every last detail of the deal.


Secondly, Phil's presentation abilities is a personal matter, so you may like it, I happen to think it is weak. That doesn't make you or I correct. Also, I'm not suggesting we just get any ol joker up on stage and ramble away not knowing the science as you insinuate. You are very black and white in your rebuttals and try to downplay any concern anyone has. The main point was that Phil shouldn't be wasting time on these presentations which have very little viewership and very little impact on the stock when any presenter could do on his behalf. These are catered to retail investors. I bet you could count the number of attendees on this call on your hands.
He is paid far too much to be doing these presentations all the time when he could be working on getting hemo/thyroid into clinicals. 


What is your rebuttal to the lack of info regarding those 2 indications? Are you satisfied with "we are working on getting hemo/thyroid" into the clinc" for the last 2 years?

Blows me away that you think everthing is being done perfectly and there is zero room for improvement. There is nothing wrong with criticizing a company you are invested in Red. Tired of your patronizing posts.

If WK is the mother-in-law who is always right, Red is the stepford wife. Pretending everything is just A OK meanwhile fully knowing the husband is out banging the neighbour and the teenage daughter blows her tennis coach.


Please give a thumbs up and click the subscribe button beow if you'd like more posts like these. 






<< Previous
Bullboard Posts
Next >>